Early Approvals, Real-World Insights, and Emerging Therapies in MASLD Care - report from EASD 2026

Dr. Cyrielle Caussy presents key insights from the EASD-EASL joint session on metabolic dysfunction-associated steatotic liver disease (MASLD) at the EASD 2026 Congress. This brief highlights early therapeutic approvals, real-world clinical data, and novel emerging treatments aimed at optimizing multidisciplinary care and improving outcomes for patients with MASLD and metabolic risk factors. Video: https://medicaldigest.org/scientific-contents/interview:early-approvals-real-world-insights-and-emerging-therapies-masld-care-2